Klin Farmakol Farm. 2005;19(4):235-238

Immunomodulation in recurrent respiratory infections

doc. MUDr. Jaromír Bystroň CSc
Oddělení alergologie a klinické imunologie, FN Olomouc

The auhor gives a brief overview of the most common causes of recurrent respiratory infections, mentions the principles of treatment for these conditions, and discusses the options of immunomodulation which can be used in the treatment of these conditions.

Keywords: Key words: recurrent respiratory infections, immunomodulation therapy.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bystroň J. Immunomodulation in recurrent respiratory infections. Klin Farmakol Farm. 2005;19(4):235-238.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Bartůňková J. Imunodeficience, Ed.: Grada Publishing, 2002.
    2. Bystroň J. O imunitě, Ed.: Mirago, Ostrava, 2000.
    3. Imunomodulace v klinické praxi. Farmakoterapeutické informace 11-12/1998; s. 4-7.
    4. Současné možnosti imunomodulace v praxi. Farmakoterapeutické informace 12/2004; s. 3-4, dokončení 1/2005, s. 1-3.
    5. Ammann AJ Biologic and immunomodulating factors in the treatment of pediatric acquired immunodeficiency syndrome.Pediatr Infect Dis J 1990 Dec; 9 (12): 894-904.
    6. Bystroň J. Antihistaminika známá a neznámá. Causa Subita, 2003; 6, No. 4: 168-170.
    7. Špičák V. Nová generace antihistaminik I. Alergie 4, No 1, 2002; 75-80.
    8. Špičák V. Nová generace antihistaminik II. Alergie 4, No 2, 2002; 152-154.
    9. Kopřiva F. Leukotrieny, Ed: Jessenius, Maxdorf 2005; 99-103.
    10. Čáp P. Kromony dnes. Alergie 2003; 5, No1: 55-58.
    11. Seberová E. Topické nazální steroidy in: Alergologie, Eds. Špičák V, Panzner P, Galén 2004; 185.
    12. Sacher RA: Intravenous immunoglobulin consensus statement. J. Allergy Clin. Immunol. 2001; 108: 139-146. Go to original source... Go to PubMed...
    13. Serell WAC, Jolles S: Immunomodulatory action of intravenous immunoglobulin. Immunol. 2002; 107: 387-393. Go to original source... Go to PubMed...
    14. Imunomodulační terapie a zkušenosti s preparátem Immodin. Ed: Sevapharma 1995.
    15. Použití preparátu Immodin v klinické praxi, Ed. Sevapharma, 2000.
    16. Schooltink H, Rose-John S. Cytokines as therapeutic drugs. J. InterferonCytokine Research 2002; 22: 505-516. Go to original source... Go to PubMed...
    17. Glasky A, Gordon J. Inosiplex treatment od acquired immunodeficiencies. A clinical model for effective immunomodulation. Meth. and Find. Exptl. Clin. Pharmac. 1986; 8 (1): 35-40.
    18. Litzman J, Lokaj J, Krejci M, Pesak S, Morgan G: Isoprinosine does not protect against frequent respiratory tract infections in childhood.Eur J Pediatr 1999 Jan; 158 (1): 32-37. Go to original source... Go to PubMed...
    19. Bystroň J. Bakteriální imunomodulátory v ORL praxi. Otorinolaryng. A Foniatr. 2000(2): 73-81.
    20. Bartůňková J. Bakteriální imunomodulátory. Causa subita 2003; 6, č.8: 384-386.
    21. Bystroň J. Perorální bakteriální imunomodulátory a věda založena na důkazech. Alergie 2003; 5, č. 4: 284-290.
    22. Litzman J. Bakteriální imunomodulátory - pro ale i proti. Alergie 2004; 6, No. 3: 180-184.
    23. Bystroň J. Jsou doplňkové léčebné postupy u léčby alergie užitečné? Alergie 4, 2002: 168-170.
    24. Bystroň J. Zůstaneme u klasické medicíny nebo se vrátíme k šamanství. Alergie 2004; 6, No. 3: 165-169.

    Return to the content


    Clinical Pharmacology and Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.